Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Diabetes

Endogenex completes enrollment in trial of endoscopic diabetes treatment

By

Endogenex announced today that it completed enrollment in the ReCET clinical study of its endoscopic diabetes treatment. ReCET enrolled 350 patients across approximately 40 clinical sites in the U.S. and Australia. It evaluates the safety and effectiveness of the Endogenex System in adult patients with T2D whose blood glucose levels are … [Read more...] about Endogenex completes enrollment in trial of endoscopic diabetes treatment

Aqua Medical shares data backing ablation procedure for treating diabetes

By

Aqua Medical today announced the presentation of 12-month follow-up data for its proprietary radiofrequency vapor ablation (RFVA) platform. Pleasanton, California-based Aqua Medical designed its Proximal Intestinal Mucosal Ablation (PIMA) procedure to use its proprietary RFVA system. PIMA, a minimally invasive outpatient endoscopic procedure, … [Read more...] about Aqua Medical shares data backing ablation procedure for treating diabetes

Endogenex closes $50M Series C extension to support endoscopic diabetes procedure

By

Endogenex announced today that it closed a $50 million extension of its Series C financing round. Arboretum Ventures joined as a new lead investor alongside existing investors participating in the round. It builds on the $88 million Series C closed in June 2024, bringing the total round to $138 million. Minneapolis-based Endogenex plans to … [Read more...] about Endogenex closes $50M Series C extension to support endoscopic diabetes procedure

Endogenex has positive data for pulsed electric field tech for diabetes

By

Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes. Minneapolis-based Endogenex develops the Endogenex ReCET technology, which uses electroporation therapy to achieve re-cellularization. It utilizes non-thermogenic pulsed electric fields (PEF) to regenerate duodenal mucosal … [Read more...] about Endogenex has positive data for pulsed electric field tech for diabetes

Portal Diabetes earns FDA breakthrough nod for implantable insulin pump

By

Portal Diabetes announced today that it received FDA breakthrough device designation for its implantable insulin pump system. The Westfield, Indiana–based company can now begin a Phase 1 study to evaluate its proprietary, temperature-stable insulin. It aims to deliver a functional cure for type 1 diabetes. Portal Diabetes developed its … [Read more...] about Portal Diabetes earns FDA breakthrough nod for implantable insulin pump

Aqua Medical wins FDA IDE to launch trial for ablation procedure that treats diabetes

By

Aqua Medical has received an investigational device exemption (IDE) from the FDA for its ablation device intended to treat diabetes, the company told MassDevice ahead of an official announcement later today. The IDE gives the device developer the green light to conduct a pilot clinical trial of its Proximal Intestinal Mucosal Ablation (PIMA) … [Read more...] about Aqua Medical wins FDA IDE to launch trial for ablation procedure that treats diabetes